These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22921736)

  • 1. The switch between relapse and remission in multiple sclerosis: continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
    Gurevich M; Achiron A
    J Neuroimmunol; 2012 Nov; 252(1-2):83-8. PubMed ID: 22921736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissions.
    Tuller T; Atar S; Ruppin E; Gurevich M; Achiron A
    Hum Mol Genet; 2011 Sep; 20(18):3606-19. PubMed ID: 21676896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term sequential analysis of sex hormones and helper T cells type 1 (Th1) and helper T cells type 2 (Th2) cytokines during and after multiple sclerosis relapse.
    de Andrés C; Rodríguez-Sáinz MC; Muñoz-Fernández MA; López-Lazareno N; Rodríguez-Mahou M; Vicente A; Fernández-Cruz E; Sánchez-Ramón S
    Eur Cytokine Netw; 2004; 15(3):197-202. PubMed ID: 15542443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis.
    Caggiula M; Batocchi AP; Frisullo G; Angelucci F; Patanella AK; Sancricca C; Nociti V; Tonali PA; Mirabella M
    Scand J Immunol; 2005 Aug; 62(2):176-82. PubMed ID: 16101825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc-ion binding and cytokine activity regulation pathways predicts outcome in relapsing-remitting multiple sclerosis.
    Achiron A; Gurevich M; Snir Y; Segal E; Mandel M
    Clin Exp Immunol; 2007 Aug; 149(2):235-42. PubMed ID: 17488294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential microRNA expression in blood in multiple sclerosis.
    Søndergaard HB; Hesse D; Krakauer M; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Dec; 19(14):1849-57. PubMed ID: 23773985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired expression of peripheral blood apoptotic-related gene transcripts in acute multiple sclerosis relapse.
    Achiron A; Feldman A; Mandel M; Gurevich M
    Ann N Y Acad Sci; 2007 Jun; 1107():155-67. PubMed ID: 17804543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of glatiramer acetate to modify the peripheral T cell repertoire of relapsing-remitting multiple sclerosis patients.
    Berthelot L; Miqueu P; Pettré S; Guillet M; Moynard J; Wiertlewski S; Lefrère F; Brouard S; Soulillou JP; Laplaud DA
    Clin Immunol; 2010 Apr; 135(1):33-42. PubMed ID: 20116333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment.
    Lindquist S; Hassinger S; Lindquist JA; Sailer M
    Mult Scler; 2011 Jul; 17(7):851-66. PubMed ID: 21561957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.
    Frisullo G; Angelucci F; Caggiula M; Nociti V; Iorio R; Patanella AK; Sancricca C; Mirabella M; Tonali PA; Batocchi AP
    J Neurosci Res; 2006 Oct; 84(5):1027-36. PubMed ID: 16865709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
    Peng X; Jin J; Giri S; Montes M; Sujkowski D; Tang Y; Smrtka J; Vollmer T; Singh I; Markovic-Plese S
    J Neuroimmunol; 2006 Sep; 178(1-2):130-9. PubMed ID: 16870268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients.
    Infante-Duarte C; Weber A; Krätzschmar J; Prozorovski T; Pikol S; Hamann I; Bellmann-Strobl J; Aktas O; Dörr J; Wuerfel J; Stürzebecher CS; Zipp F
    FASEB J; 2005 Nov; 19(13):1902-4. PubMed ID: 16144955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Fas antigen on T cell subpopulations in peripheral blood of patients with relapsing-remitting multiple sclerosis.
    Bilińska M; Frydecka I; Podemski R; Teodorowska R; Gruszka E
    Med Sci Monit; 2001; 7(2):251-5. PubMed ID: 11257731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular biomarkers for prediction of multiple sclerosis relapse].
    Satoh J
    Nihon Rinsho; 2008 Jun; 66(6):1103-11. PubMed ID: 18540355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MS risk genes are transcriptionally regulated in CSF leukocytes at relapse.
    Jernås M; Malmeström C; Axelsson M; Olsson C; Nookaew I; Wadenvik H; Zetterberg H; Blennow K; Lycke J; Rudemo M; Olsson B
    Mult Scler; 2013 Apr; 19(4):403-10. PubMed ID: 22907940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomonitoring measures in relapsing-remitting multiple sclerosis.
    Matsui M; Araya SI; Wang HY; Matsushima K; Saida T
    J Neuroimmunol; 2004 Mar; 148(1-2):192-9. PubMed ID: 14975601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Farhum F; Karni A
    J Neurol Sci; 2010 Aug; 295(1-2):31-7. PubMed ID: 20541775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression study.
    Gurevich M; Gritzman T; Orbach R; Tuller T; Feldman A; Achiron A
    J Neuroimmunol; 2010 Apr; 221(1-2):87-94. PubMed ID: 20347159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXP3 gene expression in multiple sclerosis patients pre- and post mesenchymal stem cell therapy.
    Mohajeri M; Farazmand A; Mohyeddin Bonab M; Nikbin B; Minagar A
    Iran J Allergy Asthma Immunol; 2011 Sep; 10(3):155-61. PubMed ID: 21891821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.